BeOne Medicines Ltd. - 24 Sep 2021 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role
10%+ Owner
Signature
BeiGene, Ltd. /s/ Scott A. Samuels, SVP, General Counsel
Issuer symbol
LPTX
Transactions as of
24 Sep 2021
Net transactions value
+$7,249,830
Form type
4
Filing time
28 Sep 2021, 17:48:31 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LPTX Common Stock Purchase $7,249,830 +2,543,800 +53% $2.85 7,348,437 24 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 24, 2021, BeiGene, Ltd. purchased 2,543,800 shares of common stock of the Issuer for $2.85 per share pursuant to an underwritten public offering.